G Medical Innovations Holdings Ltd

GMVDFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$25992

P/E Ratio—

52W High$0.0251

52W Low$0.00001

Avg Volume5K

Open$0.00

Beta-1.18

Overview

Foreign Private Issuer · Files 20-F / 6-K

G Medical Innovations Holdings Ltd (GMVDF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001760764 · GMVDF · OTC · as of Jun 9, 2026

Filing snapshot

177

Total Filings

Latest Form

2024-07-22

Most Recent

2021

Filing Since

Financials Earnings View All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001760764 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY

Filed Date

2023-05-16

Fiscal Year End

May 16, 2023

Accession No.

0001213900-23-040099

Primary Document

f20f2022_gmedical.htm

View on SEC EDGAR Download PDF Filing Index

Source: data.sec.gov · CIK 0001760764 · Accession 0001213900-23-040099

Latest Key Filings

6-KQuarterly Report

REPORT OF FOREIGN PRIVATE ISSUER

2023-12-18

View 6-K on SEC

8-KCurrent Report

No recent filings

Form 4Insider Activity

Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144

Filed Date

Form Type

Description

View

2024-07-22

REGISTRATION WITHDRAWAL

0001013762-24-000350

View

RWRW

REGISTRATION WITHDRAWAL

2024-07-22

View

2024-04-12

SC 13D/A

AMENDMENT NO. 3 TO SCHEDULE 13D

0001213900-24-032400

View

SC 13D/ASC 13D/A

AMENDMENT NO. 3 TO SCHEDULE 13D

2024-04-12

View

2024-02-07

SC 13D/A

AMENDMENT NO. 2 TO SCHEDULE 13D

0001213900-24-010956

View

SC 13D/ASC 13D/A

AMENDMENT NO. 2 TO SCHEDULE 13D

2024-02-07

View

2023-12-18

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-23-096532

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2023-12-18

View

2023-11-29

6-K

Current Report (Foreign Issuer)

CURRENT REPORT

0001213900-23-090764

View

6-KCurrent Report (Foreign Issuer)

CURRENT REPORT

2023-11-29

View

2023-10-25

0001013762-23-006460

View

2023-10-25

View

2023-10-24

SC 13D/A

AMENDMENT NO. 1 TO SCHEDULE 13D

0001013762-23-006270

View

SC 13D/ASC 13D/A

AMENDMENT NO. 1 TO SCHEDULE 13D

2023-10-24

View

2023-10-12

25-NSE

0001354457-23-000760

View

25-NSE25-NSE

25-NSE

2023-10-12

View

2023-10-10

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001013762-23-002818

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2023-10-10

View

2023-09-22

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-23-078763

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2023-09-22

View

2023-09-13

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-23-076368

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2023-09-13

View

2023-08-25

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-23-070923

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2023-08-25

View

2023-08-25

SC 13D/A

AMENDMENT NO. 2 TO SCHEDULE 13D

0001213900-23-070922

View

SC 13D/ASC 13D/A

AMENDMENT NO. 2 TO SCHEDULE 13D

2023-08-25

View

2023-08-25

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-23-070904

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2023-08-25

View

2023-08-25

6-K

Current Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

0001213900-23-070724

View

6-KCurrent Report (Foreign Issuer)

REPORT OF FOREIGN PRIVATE ISSUER

2023-08-25

View

Showing 1–15 of 176 filingsForm 4 / 144 hidden· 177 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov) | Updated: Hourly | CIK: 0001760764 | Exchange: OTC · Healthcare

G Medical Innovations Holdings Ltd (OTC: GMVDF) has submitted 177 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001760764, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is G Medical Innovations Holdings Ltd's most comprehensive regulatory disclosure. The most recent G Medical Innovations Holdings Ltd 10-K was filed on 2023-05-16 for fiscal year ending 2023. Historical GMVDF 10-K annual reports are available from 2018 through 2023.

Investors researching G Medical Innovations Holdings Ltd SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Related Companies SEC Filings — Healthcare

KALY SEC Filings →ACUR SEC Filings →FLHLF SEC Filings →MCRT SEC Filings →CBDX SEC Filings →AZFL SEC Filings →GNLKQ SEC Filings →ECGI SEC Filings →

→ GMVDF Financials → GMVDF Earnings → GMVDF Insider Trades

Frequently Asked Questions

GMVDF SEC Filings · 8 questions

G Medical Innovations Holdings Ltd (GMVDF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 177 filings and access original documents at no cost. G Medical Innovations Holdings Ltd's CIK is 0001760764.

GMVDF SEC filingsG Medical Innovations Holdings Ltd SEC documentsfind GMVDF 10-K